XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities    
Net loss $ (103,306,000) $ (49,969,000)
Adjustments to reconcile net loss to net cash used for operating activities:    
Share-based compensation expense 19,246,000 9,694,000
Depreciation expense 2,088,000 581,000
Loss on disposal of equipment 150,000 0
Interest expense 1,655,000 0
Changes in operating assets and liabilities:    
Accounts receivable, net (372,000) 0
Inventory (939,000) 0
Prepaid expenses and other current assets (2,135,000) (270,000)
Other assets 0 219,000
Accounts payable (5,415,000) (732,000)
Accrued expenses 4,608,000 (541,000)
Accrued payroll and related expenses (377,000) (214,000)
Deferred rent 1,376,000 0
Net cash used for operating activities (83,421,000) (41,232,000)
Investing activities    
Purchase of property and equipment (1,881,000) (2,021,000)
Net cash used for investing activities (1,881,000) (2,021,000)
Financing activities    
Net proceeds from royalty financing 124,289,000 0
Net proceeds from the issuance of common stock 109,809,000 117,480,000
Proceeds from the exercise of stock options for common stock 1,716,000 2,074,000
Net cash provided by financing activities 235,814,000 119,554,000
Net increase in cash, cash equivalents and restricted cash 150,512,000 76,301,000
Cash, cash equivalents and restricted cash at beginning of period 91,824,000 65,926,000
Cash, cash equivalents and restricted cash at end of period 242,336,000 142,227,000
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets    
Total cash, cash equivalents and restricted cash $ 91,824,000 $ 65,926,000